Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies
Authors:
Open Access
- 19 August 2010
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 24 (10) , 1799-1804
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Novel homo- and hemizygous mutations in EZH2 in myeloid malignanciesLeukemia, 2010
- Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignanciesBlood, 2010
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center originNature Genetics, 2010
- Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid MalignanciesJournal of Clinical Oncology, 2009
- TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17pLeukemia, 2009
- Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasmsBlood, 2009
- Mutation inTET2in Myeloid CancersNew England Journal of Medicine, 2009
- UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutationLeukemia, 2008
- Whole genome scanning as a cytogenetic tool in hematologic malignanciesBlood, 2008
- A new approach to the study of the base-excision repair pathway using methoxyamine.Journal of Biological Chemistry, 1985